Pascal Biosciences Creates Development Science Lab in Seattle WA
May 09, 2017 12:20 ET
|
Pascal Biosciences Inc.
VANCOUVER, BRITISH COLUMBIA--(Marketwired - May 9, 2017) -
NOT FOR DISTRIBUTION TO THE U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
Pascal Biosciences...
bioMmune Announces Name Change to Pascal Biosciences Inc.
March 30, 2017 20:09 ET
|
bioMmune Technologies Inc.
VANCOUVER, BRITISH COLUMBIA--(Marketwired - March 30, 2017) -
NOT FOR DISTRIBUTION TO THE U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
bioMmune...
BioMmune Appoints Thomas Gadek, PhD, to Board of Directors
September 20, 2016 09:30 ET
|
BioMmune Technologies Inc.
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Sept. 20, 2016) -
NOT FOR DISTRIBUTION TO THE U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
bioMmune...
BioMmune, A 2016 TSX Venture Top 50 Company, Awarded Patent for Calcium Channel Monoclonal Antibodies
June 29, 2016 08:45 ET
|
BioMmune Technologies Inc.
VANCOUVER, BRITISH COLUMBIA--(Marketwired - June 29, 2016) - bioMmune Technologies Inc. ("bioMmune" or the "Company") (TSX VENTURE:IMU) has been awarded its first patent for monoclonal...
BioMmune Appoints Dr. Patrick Gray as New Chief Executive Officer and President
April 22, 2016 08:45 ET
|
BioMmune Technologies Inc.
VANCOUVER, BRITISH COLUMBIA--(Marketwired - April 22, 2016) - BioMmune Technologies Inc. ("BioMmune" or the "Company") (TSX VENTURE:IMU), a company focused on harnessing the body's immune...
bioMmune Technologies Inc. Announces Appointment of Directors
December 09, 2015 00:31 ET
|
BioMmune Technologies Inc.
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Dec. 9, 2015) - bioMmune Technologies Inc. ("bioMmune" or the "Company") (TSX VENTURE:IMU), a company focused on harnessing the body's immune...
BioMmune Technologies Inc.: Appointment of Chief Scientific Officer
November 19, 2015 09:30 ET
|
BioMmune Technologies Inc.
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Nov. 19, 2015) - BioMmune Technologies Inc. ("Biommune" or the "Company") (TSX VENTURE:IMU), a company focused on harnessing the body's immune...
BioMmune Technologies Inc. Announces Non-Brokered Private Placement
October 11, 2015 17:40 ET
|
BioMmune Technologies Inc.
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Oct. 11, 2015) - BioMmune Technologies Inc. (the "Company") (TSX VENTURE:IMU), announces a non-brokered private placement of up to 2,000,000...
BioMmune Technologies Inc. Grants Stock Options
August 04, 2015 15:06 ET
|
BioMmune Technologies Inc.
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Aug. 4, 2015) - BioMmune Technologies Inc. (TSX VENTURE:IMU) (the "Company") is pleased to announce that pursuant to the Company's Incentive...
BioMmune Technologies Inc. Announces the Appointment of a New Director
June 30, 2015 16:05 ET
|
BioMmune Technologies Inc.
VANCOUVER, BRITISH COLUMBIA--(Marketwired - June 30, 2015) - BioMmune Technologies Inc., (TSX VENTURE:IMU) (the "Company") is pleased to announce the appointment of Mr. Jens Biertumpel as...